Literature DB >> 11356444

Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.

A Hoerauf1, S Mand, O Adjei, B Fleischer, D W Büttner.   

Abstract

Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control. This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough. Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356444     DOI: 10.1016/S0140-6736(00)04581-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  73 in total

1.  Update on Lymphatic Filarial Infections.

Authors:  Paul B. Keiser; Thomas B. Nutman
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 2.  Onchocerciasis.

Authors:  Achim Hoerauf; Dietrich W Büttner; Ohene Adjei; Eric Pearlman
Journal:  BMJ       Date:  2003-01-25

3.  The bacterial catalase from filarial DNA preparations derives from common pseudomonad contaminants and not from Wolbachia endosymbionts.

Authors:  Jeremy Foster; Laura Baldo; Mark Blaxter; Kimberly Henkle-Dührsen; Claire Whitton; Barton Slatko; Claudio Bandi
Journal:  Parasitol Res       Date:  2004-09       Impact factor: 2.289

Review 4.  The pharmacokinetics and interactions of ivermectin in humans--a mini-review.

Authors:  Aránzazu González Canga; Ana M Sahagún Prieto; M José Diez Liébana; Nélida Fernández Martínez; Matilde Sierra Vega; Juan J García Vieitez
Journal:  AAPS J       Date:  2008-01-25       Impact factor: 4.009

5.  Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.

Authors:  Achim Hoerauf; Sabine Specht; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Sabine Mand; Linda Batsa; Norbert Brattig; Peter Konadu; Claudio Bandi; Rolf Fimmers; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

6.  Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis.

Authors:  George A Punkosdy; David G Addiss; Patrick J Lammie
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus.

Authors:  Sabine Specht; Sabine Mand; Yeboah Marfo-Debrekyei; Alexander Yaw Debrah; Peter Konadu; Ohene Adjei; Dietrich W Büttner; Achim Hoerauf
Journal:  Parasitol Res       Date:  2008-08-05       Impact factor: 2.289

8.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.

Authors:  Achim Hoerauf; Sabine Specht; Marcelle Büttner; Kenneth Pfarr; Sabine Mand; Rolf Fimmers; Yeboah Marfo-Debrekyei; Peter Konadu; Alexander Yaw Debrah; Claudio Bandi; Norbert Brattig; Anna Albers; John Larbi; Linda Batsa; Mark J Taylor; Ohene Adjei; Dietrich W Büttner
Journal:  Med Microbiol Immunol       Date:  2007-11-13       Impact factor: 3.402

Review 9.  Filariasis and lymphoedema.

Authors:  K M Pfarr; A Y Debrah; S Specht; A Hoerauf
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

10.  Brugia malayi gene expression in response to the targeting of the Wolbachia endosymbiont by tetracycline treatment.

Authors:  Elodie Ghedin; Tiruneh Hailemariam; Jay V DePasse; Xu Zhang; Yelena Oksov; Thomas R Unnasch; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2009-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.